<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04868383</url>
  </required_header>
  <id_info>
    <org_study_id>20478</org_study_id>
    <nct_id>NCT04868383</nct_id>
  </id_info>
  <brief_title>Using Smart Phone Technology to Support PrEP Uptake and Adherence</brief_title>
  <acronym>prep'd</acronym>
  <official_title>Using Smart Phone Technology to Support PrEP Uptake and Adherence in Virginia - Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Department of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single arm pilot study of a new smartphone app to support adherence to PrEP&#xD;
      medication for HIV prevention in public clinics in Virginia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Testing the impact of a smart phone application's impact on PrEP uptake and adherence.&#xD;
&#xD;
      The app features daily medication reminders, daily mood and stress evaluations, a community&#xD;
      message board for social support, and patient-provider secure, HIPAA compliant private&#xD;
      messaging between patients and clinic providers. Participants will be recruited from VDH&#xD;
      clinics. We will evaluate the adherence and uptake rates of PrEP among study participants.&#xD;
      Usage data will be collected from the application, and from participant surveys at 30 day, 3&#xD;
      month, and 6 month study timepoints. Surveys will include questionnaires on medication&#xD;
      adherence, empathy of providers, experiences with the app, stigma and disclosure attitudes,&#xD;
      and social support, along with mental health screening. The study will be analyzed as a&#xD;
      prospective one arm study by comparing baseline to 3M and 6M surveys, along with examining&#xD;
      and characterizing app usage across time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>6 months</time_frame>
    <description>Overall percentage of PrEP medication adherence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usability</measure>
    <time_frame>6 months</time_frame>
    <description>How usable is the app to both patient participants and provider participants</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>HIV Prevention</condition>
  <condition>PrEP</condition>
  <condition>Adherence, Medication</condition>
  <arm_group>
    <arm_group_label>Single pilot arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this single arm pilot study, all participants will receive access to a novel smartphone app designed to support PrEP uptake and adherence for a 6 month period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of smart phone technology to support medication adherence and uptake</intervention_name>
    <description>Use of smart phone technology to support medication adherence and uptake</description>
    <arm_group_label>Single pilot arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  one or considering being on PrEP for HIV prevention&#xD;
&#xD;
          -  Patient at a VDH or VDH funded clinic&#xD;
&#xD;
          -  ability to read at a 5th grade reading level&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV positive individuals&#xD;
&#xD;
          -  Persons under the age of 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Virginia Department of Health</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Karen Ingersoll</investigator_full_name>
    <investigator_title>Clinical Psychologist</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Prevention</keyword>
  <keyword>Adherence</keyword>
  <keyword>Uptake</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

